Commentary: an updated review of the published studies of homocysteine and cardiovascular disease.

Commentary: an updated review of the published studies of homocysteine and cardiovascular disease.

Podrobná bibliografie
Hlavní autor:	Clarke, R
Médium:	Journal article
Jazyk:	English
Vydáno:	2002

Podobné jednotky

Homocysteine and vascular disease: Review of published results of the homocysteine-lowering trials
Autor: Clarke, R, a další
Vydáno: (2011)

Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials.
Autor: Clarke, R, a další
Vydáno: (2011)

Homocysteine and cardiovascular disease. Overview.
Autor: Clarke, R
Vydáno: (1998)

Homocysteine, B vitamins, and the risk of cardiovascular disease.
Autor: Clarke, R
Vydáno: (2011)

Homocysteine, renal function, and risk of cardiovascular disease.
Autor: Clarke, R, a další
Vydáno: (2003)

Homocysteine-lowering And Cardiovascular Disease: Is The Door Closing Now
Autor: Clarke, R
Vydáno: (2009)

Homocysteine, B-vitamins, and the risk of cardiovascular disease.
Autor: Clarke, R, a další
Vydáno: (2005)

Homocysteine and risk of cardiovascular disease and venous thrombosis
Autor: Clarke, R, a další
Vydáno: (2003)

Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies.
Autor: Danesh, J, a další
Vydáno: (1998)

Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies.
Autor: Den Heijer, M, a další
Vydáno: (2005)

Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies.
Autor: Clarke, R, a další
Vydáno: (2001)

Homocysteine, B vitamins, and cardiovascular disease
Autor: Refsum, H, a další
Vydáno: (2006)

Homocysteine, B vitamins, and cardiovascular disease.
Autor: Refsum, H, a další
Vydáno: (2006)

Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia.
Autor: Clarke, R, a další
Vydáno: (2007)

Homocysteine and coronary heart disease.
Autor: Clarke, R, a další
Vydáno: (2002)

Homocysteine, the kidney, and vascular disease.
Autor: Haynes, R, a další
Vydáno: (2012)

Homocysteine, the kidney, and vascular disease Moderate differences in homocysteine concentrations do not cause vascular disease
Autor: Haynes, R, a další
Vydáno: (2012)

Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
Autor: Clarke, R, a další
Vydáno: (2000)

Assessment of homocysteine as a cardiovascular risk factor in clinical practice.
Autor: Clarke, R, a další
Vydáno: (2001)

Detecting homocysteine in cardiovascular disease using aptasensors: A review
Autor: Sara Ranjbari, a další
Vydáno: (2023-12-01)

Homocysteine and prediction of coronary heart disease and stroke
Autor: Clarke, R, a další
Vydáno: (2003)

Homocysteine and cardiovascular risk: considering the evidence in the context of study design, folate fortification, and statistical power.
Autor: Ueland, P, a další
Vydáno: (2007)

Homocysteine-lowering trials for prevention of heart disease and stroke.
Autor: Clarke, R
Vydáno: (2005)

Homocysteine, grey matter and cognitive function in adults with cardiovascular disease.
Autor: Andrew H Ford, a další
Vydáno: (2012-01-01)

HOMOCYSTEINE, LARGE ARTERIES AND CARDIOVASCULAR RISK
Autor: Jan Filipovský
Vydáno: (2007-08-01)

Elevated plasma total homocysteine increased the risk of dementia in the elderly: Commentary
Autor: Sheehan, B, a další
Vydáno: (2002)

Citation of updated and co-published Cochrane Methodology Reviews
Autor: Linlin Zhu, a další
Vydáno: (2023-07-01)

Homocysteine and Folic Acid: Risk Factors for Alzheimer's Disease—An Updated Meta-Analysis
Autor: Qianwen Wang, a další
Vydáno: (2021-05-01)

Role of Homocysteine in Diseases: A Review
Autor: Maryam Moradi Binabaj, a další
Vydáno: (2016-09-01)

Homocysteine, B vitamins, and the risk of dementia.
Autor: Clarke, R
Vydáno: (2007)

Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease.
Autor: Clarke, R, a další
Vydáno: (1998)

Homocysteine levels and risk of essential hypertension: A meta-analysis of published epidemiological studies
Autor: Fade Zhong, a další
Vydáno: (2017-02-01)

The Impact of Cardiovascular Disease Gene Polymorphism and Interaction with Homocysteine on Deep Vein Thrombosis
Autor: Lei-Lei Niu, a další
Vydáno: (2024-09-01)

Cardiovascular disease among patients with type 2 diabetes: role of homocysteine as an inflammatory marker
Autor: Ashok Sahu, a další
Vydáno: (2016-04-01)

Homocysteine And Neurological Disease
Autor: Nagaraja D
Vydáno: (2004-01-01)

Broken instrument may incidentally be found in second surgery: Update and commentary on a previously published article
Autor: Ganesh Singh Dharmshaktu, a další
Vydáno: (2021-01-01)

The hordaland homocysteine study: A community-based study of homocysteine, its determinants, and associations with disease
Autor: Refsum, H, a další
Vydáno: (2006)

Therapeutical approach to plasma homocysteine and cardiovascular risk reduction
Autor: Marcello Ciaccio, a další
Vydáno: (2008-03-01)

Features of Plasma Homocysteine, Vitamin B12, and Folate in Parkinson's Disease: An Updated Meta-Analysis
Autor: Yiti Liu, a další
Vydáno: (2023-08-01)

A Review of Psoriasis, a Known Risk Factor for Cardiovascular Disease and Its Impact on Folate and Homocysteine Metabolism
Autor: Ian McDonald, a další
Vydáno: (2012-01-01)